Investigator Site 0010116 — Springdale, Arkansas

Investigator Site 0010116 is a clinical research site located in Springdale, Arkansas, United States 72758.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigator Site 0010116 has participated in 1 clinical trials.

Therapeutic areas: Primary Immune Thrombocytopenia.

Sponsors: argenx.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Springdale

Browse all research sites in Arkansas · View every site in Springdale

• University of Arkansas for Medical Sciences Northwest
• Highlands Oncology Group
• Research Site
• Highlands Oncology Group, PA
• Highlands Oncology Group Springdale
• Alkermes Investigational Site
• Highlands Oncology
• Retina Partners of Northwest Arkansas, PLLC
• Northwest Arkansas Retina Associates
• UAMS Institute for Community Health Innovation
• Pfizer Investigational Site
• Woodland Research Northwest

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 0010116?

Investigator Site 0010116 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 0010116 conducted?

Investigator Site 0010116 has 1 clinical trials on record. Their work covers Primary Immune Thrombocytopenia.

Is Investigator Site 0010116 accredited by Crixeo Clinical Trials?

Investigator Site 0010116 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 0010116?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.